Preliminary results from this 6 month trial highlight a significant reduction in PVR while the other primary endpoint, the 6 min walk distance (6MWD), did not reach statistical significance.
← all excerpts
Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?
1
—
—